Cargando…

Author Correction: Secukinumab Demonstrates Significantly Lower Immunogenicity Potential Compared to Ixekizumab

Detalles Bibliográficos
Autores principales:	Spindeldreher, Sebastian, Maillère, Bernard, Correia, Evelyne, Tenon, Maxime, Karle, Anette, Jarvis, Philip, Kolbinger, Frank
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2018
Materias:	Author Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6002311/ https://www.ncbi.nlm.nih.gov/pubmed/29551008 http://dx.doi.org/10.1007/s13555-018-0234-5

Ejemplares similares

Secukinumab Demonstrates Significantly Lower Immunogenicity Potential Compared to Ixekizumab
por: Spindeldreher, Sebastian, et al.
Publicado: (2018)

T cell epitope mapping of secukinumab and ixekizumab in healthy donors
por: Spindeldreher, Sebastian, et al.
Publicado: (2020)

Secukinumab, a novel anti–IL-17A antibody, shows low immunogenicity potential in human in vitro assays comparable to other marketed biotherapeutics with low clinical immunogenicity
por: Karle, Anette, et al.
Publicado: (2016)

Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA
por: Fitzgerald, Timothy, et al.
Publicado: (2023)

Cost effectiveness of ixekizumab versus secukinumab in the treatment of moderate-to-severe plaque psoriasis in Spain
por: Johansson, Erin, et al.
Publicado: (2018)

Outcomes in Ixekizumab Patients Following Exposure to Secukinumab and Other Biologics in the CorEvitas Psoriasis Registry
por: Lockshin, Benjamin, et al.
Publicado: (2022)

Response to the Letter to the Editor: Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA
por: Fitzgerald, Timothy, et al.
Publicado: (2023)

Tregitopes and impaired antigen presentation: Drivers of the immunomodulatory effects of IVIg?
por: Sordé, Laetitia, et al.
Publicado: (2017)

Massive immune response against IVIg interferes with response against other antigens in mice: A new mode of action?
por: Sordé, Laetitia, et al.
Publicado: (2017)

Characterization of CD4 T Cell Epitopes of Infliximab and Rituximab Identified from Healthy Donors
por: Hamze, Moustafa, et al.
Publicado: (2017)

Author Correction: Demonstration of quantum-digital payments
por: Schiansky, Peter, et al.
Publicado: (2023)

Cost-effectiveness analysis of ixekizumab versus secukinumab in patients with psoriatic arthritis and concomitant moderate-to-severe psoriasis in Spain
por: Schweikert, Bernd, et al.
Publicado: (2020)

Author Correction: Molecular mechanism of phosphopeptide neoantigen immunogenicity
por: Patskovsky, Yury, et al.
Publicado: (2023)

Applying MAPPs Assays to Assess Drug Immunogenicity
por: Karle, Anette C.
Publicado: (2020)

Treatment with Ixekizumab Following Secukinumab Failure in Patients with Psoriatic Arthritis: Real-Life Experience from a Resistant Population
por: Berman, Julia, et al.
Publicado: (2021)

Healthcare Costs Among Patients with Psoriasis Treated with Ixekizumab Versus Secukinumab in Real-World Settings Over 24 Months
por: Blauvelt, Andrew, et al.
Publicado: (2022)

Letter to the Editor: Response to Fitzgerald T et al. Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA
por: Blauvelt, Andrew, et al.
Publicado: (2023)

Combining deep mutational scanning to heatmap of HLA class II binding of immunogenic sequences to preserve functionality and mitigate predicted immunogenicity
por: Sivelle, Coline, et al.
Publicado: (2023)

Author Correction: Uncoupling of invasive bacterial mucosal immunogenicity from pathogenicity
por: Pfister, Simona P., et al.
Publicado: (2021)

Author Correction: Demonstration of facilitation between microalgae to face environmental stress
por: Krichen, Emna, et al.
Publicado: (2020)

Comparison of Real-World Treatment Patterns Among Biologic-Experienced Patients with Psoriasis Treated with Ixekizumab or Secukinumab Over 18 Months
por: Blauvelt, Andrew, et al.
Publicado: (2021)

Author Correction: Modern Anesthetic Ethers Demonstrate Quantum Interactions with Entangled Photons
por: Burdick, Ryan K., et al.
Publicado: (2021)

Author Correction: Demonstration of speckle resistance using space–time light sheets
por: Diouf, Mbaye, et al.
Publicado: (2022)

Author Correction: A Engineered immunogen binding to alum adjuvant enhances humoral immunity
por: Moyer, Tyson J., et al.
Publicado: (2020)

Author Correction: Targeted scavenging of extracellular ROS relieves suppressive immunogenic cell death
por: Deng, Hongzhang, et al.
Publicado: (2021)

Author Correction: Demonstration of Shor’s factoring algorithm for N = 21 on IBM quantum processors
por: Skosana, Unathi, et al.
Publicado: (2023)

Author Correction: Demonstration of Shor’s factoring algorithm for N = 21 on IBM quantum processors
por: Skosana, Unathi, et al.
Publicado: (2023)

Secukinumab does not impair the immunogenic response to the influenza vaccine in patients
por: Richi, Patricia, et al.
Publicado: (2019)

Author Correction: Crizotinib-induced immunogenic cell death in non-small cell lung cancer
por: Liu, Peng, et al.
Publicado: (2019)

Author Correction: Demonstration of sub-luminal propagation of single-cycle terahertz pulses for particle acceleration
por: Walsh, D. A., et al.
Publicado: (2017)

Author Correction: A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2
por: Tamura, Ryota, et al.
Publicado: (2020)

Psoriasis patients utilizing secukinumab, ixekizumab, or brodalumab – comparisons to prior biologic medication adherence levels, reasons for switching, and reported changes in disease symptoms
por: Baiano, Renee, et al.
Publicado: (2019)

Cost-Effectiveness Analysis of Sequential Biologic Therapy with Ixekizumab Versus Secukinumab in the Treatment of Active Psoriatic Arthritis with Concomitant Moderate-to-Severe Psoriasis in the UK
por: Schweikert, Bernd, et al.
Publicado: (2020)

Author Correction: The potential utility of hybrid photo-crosslinked hydrogels with non-immunogenic component for cartilage repair
por: Wang, Yili, et al.
Publicado: (2022)

Author Correction: Deoxygenation lowers the thermal threshold of coral bleaching
por: Alderdice, Rachel, et al.
Publicado: (2023)

Author Correction: Piscine orthoreovirus demonstrates high infectivity but low virulence in Atlantic salmon of Pacific Canada
por: Polinski, Mark P., et al.
Publicado: (2020)

Author Correction: Adaptation of muscle activation after patellar loading demonstrates neural control of joint variables
por: Barroso, Filipe O., et al.
Publicado: (2021)

The seroconversion rate of QuantiFERON-TB Gold In-Tube test in psoriatic patients receiving secukinumab and ixekizumab, the anti-interleukin-17A monoclonal antibodies
por: Wu, Chen-Yu, et al.
Publicado: (2019)

Author Correction: Mimicking immune signatures of flavivirus infection with targeted adjuvants improves dengue subunit vaccine immunogenicity
por: Bidet, Katell, et al.
Publicado: (2019)

Author Correction: Demonstration of Container Effects on Recognition Process of Liquids Using a Ring-Resonator Measurement Method
por: Ozturk, Turgut
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4ktar1ntmlhtca3alavcrgpjmn